Qian JiaLe, Lv XiuQiang, Luo YongJun, Liu YiJie, Jiang Weimin
Department of Orthopaedic Surgery, The Fourth Affiliated Hospital of Soochow University, Suzhou, China.
Department of Nursing, The First Affiliated Hospital of Soochow University, Suzhou, China.
World Neurosurg. 2025 Jan;193:957-963. doi: 10.1016/j.wneu.2024.09.102. Epub 2024 Oct 16.
Posterior ring apophysis separation (PRAS) associated with lumbar disc herniation (LDH) is a relatively rare form of disc herniation. This study aims to evaluate the clinical effectiveness of unilateral biportal endoscopic discectomy (UBE) and percutaneous endoscopic lumbar discectomy (PELD) in the treatment of PRAS with LDH.
We enrolled 41 patients who met the inclusion criteria to undergo either UBE (15 cases) or PELD (26 cases) between October 2022 and October 2023. Perioperative evaluation parameters included mean operative time, hemoglobin (Hb) loss, length of stay (LOS), and postoperative complications. Outcomes were assessed at admission, as well as at 1, 3, and 6 months postsurgery using the Visual Analog Scale (VAS) and the Oswestry Disability Index (ODI). Additionally, we evaluated the results according to the modified MacNab criteria.
Both groups demonstrated improvements in postoperative VAS and ODI scores. However, there were no significant differences between the 2 groups in VAS and ODI scores before surgery, or at 1, 3, and 6 months postsurgery. Additionally, no notable differences were observed in the modified MacNab criteria. The UBE group experienced greater Hb loss, longer mean operative time, and increased LOS compared to the PELD group. Furthermore, 2 patients in the PELD group reported recurrence, while one patient in the UBE group experienced a dural tear.
UBE and PELD possess strong clinical effectiveness for treating PRAS with LDH. Although the UBE group had a longer mean operative time and LOS, with more Hb loss, the UBE group had a lower recurrence rate. Therefore, UBE remains safe and innovative for the treatment of PRAS with LDH.
与腰椎间盘突出症(LDH)相关的后环骨骺分离(PRAS)是一种相对罕见的椎间盘突出形式。本研究旨在评估单侧双通道内镜下椎间盘切除术(UBE)和经皮内镜下腰椎间盘切除术(PELD)治疗合并PRAS的LDH的临床疗效。
我们纳入了41例符合纳入标准的患者,于2022年10月至2023年10月期间接受UBE手术(15例)或PELD手术(26例)。围手术期评估参数包括平均手术时间、血红蛋白(Hb)丢失量、住院时间(LOS)和术后并发症。在入院时以及术后1、3和6个月使用视觉模拟量表(VAS)和Oswestry功能障碍指数(ODI)评估结果。此外,我们根据改良的MacNab标准评估结果。
两组术后VAS和ODI评分均有所改善。然而,两组在术前、术后1、3和6个月的VAS和ODI评分方面无显著差异。此外,在改良的MacNab标准方面未观察到明显差异。与PELD组相比,UBE组的Hb丢失量更大,平均手术时间更长,住院时间增加。此外,PELD组有2例患者报告复发,而UBE组有1例患者发生硬脊膜撕裂。
UBE和PELD在治疗合并PRAS的LDH方面具有较强的临床疗效。尽管UBE组的平均手术时间和住院时间较长,Hb丢失量较多,但UBE组的复发率较低。因此,UBE在治疗合并PRAS的LDH方面仍然安全且具有创新性。